Tonix is committed to improving the lives of patients by identifying, researching and developing promising therapies which have the potential to address unmet needs.
Phase III – Fibromyalgia
A double-blind, randomized, multicenter, placebo-controlled study to evaluate the efficacy and safety of TNX-102 SL taken daily at bedtime in patients with Fibromyalgia in 30 locations in the US.
To see if you pre-qualify, please visit https://resilientstudy.com/ and click “See if You Qualify” to find a participating site near you. If no sites are found near you, please try again in a month as some sites may be available later.
The below are a few patient advocacy organizations that provide resources and support to those affected by Fibromyalgia: